Table 1.
Cell line | EBV status | Continent | Histology | Tissue source | ||
---|---|---|---|---|---|---|
American Burkitt’s Lymphoma | AABCL | IOC-9 | Positive | N. America | Burkitt’s | Peripheral blood |
2F7 | Positive | N. America | Burkitt’s | Peripheral blood | ||
HBL-1 | Positive | N. America | UL | Peripheral blood | ||
HBL-2 | Negative | N. America | UL | Pleural effusion | ||
HBL-3 | Negative | N. America | UL | Liver | ||
Non-AABCL | EW36 | Negative | N. America | UL | Pleural effusion | |
CA46 | Negative | N. America | Burkitt’s | Ascitic fluid | ||
ST486 | Negative | N. America | UL | Ascitic fluid | ||
MC116 | Negative | N. America | UL | Pleural effusion | ||
BJAB | Negative | N. America | Burkitt’s-like | Lymphoblastoid | ||
B958 | Positive | N. America | Burkitt’s-like | Lymphoblastoid | ||
African Burkitt’s lymphoma | Non-AABCL | RAJI | Positive | Africa | Burkitt’s | Jaw tumour |
DAUDI | Positive | Africa | Burkitt’s | Orbital tumour | ||
NAMALVA | Positive | Africa | Burkitt’s | Lymphoblastoid |
AABCL, acquired immune deficiency syndrome (AIDS)-associated B-cell line; EBV, Epstein-Barr virus; UL, undifferentiated lymphoma.